Update on Spondyloarthropathies
暂无分享,去创建一个
[1] M. Dougados,et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. , 1999, The Journal of rheumatology.
[2] B. Amor. Reiter's syndrome. Diagnosis and clinical features. , 1998, Rheumatic diseases clinics of North America.
[3] L. D. de Witte,et al. Continuation of group physical therapy is necessary in ankylosing spondylitis: results of a randomized controlled trial. , 1994, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[4] A Calin,et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. , 1996, Annals of the rheumatic diseases.
[5] A. Bowcock,et al. The genetics of psoriasis: a complex disorder of the skin and immune system. , 1998, Human molecular genetics.
[6] D. Wakefield,et al. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. , 1999, Arthritis and rheumatism.
[7] Judy H. Cho,et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.
[8] S. van der Linden,et al. Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trial. , 1994, The Journal of rheumatology.
[9] J. Braun,et al. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. , 2000, Arthritis and rheumatism.
[10] P. Njobvu,et al. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. , 2000, The Journal of rheumatology.
[11] T. Castelló,et al. Traumatic spinal cord injury complicating ankylosing spondylitis , 1998, Spinal Cord.
[12] P Wordsworth,et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. , 1997, Arthritis and rheumatism.
[13] H. Zeidler,et al. Undifferentiated spondyloarthropathies. , 1992, Rheumatic diseases clinics of North America.
[14] P. Bowness,et al. Jekyll and Hyde: the transformation of HLA-B27. , 2000, Immunology today.
[15] C Wilson,et al. HLA molecules, bacteria and autoimmunity. , 2000, Journal of medical microbiology.
[16] E. Märker-Hermann,et al. CD4+ and CD8+ clonal T cell expansions indicate a role of antigens inankylosing spondylitis; a study in HLA‐B27+ monozygotic twins , 2001, Clinical and experimental immunology.
[17] Aneurysmal dilatation of ascending aorta and aortic insufficiency in juvenile spondyloarthropathy. , 1997, Scandinavian journal of rheumatology.
[18] J. Braun,et al. Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides , 2001, Current opinion in rheumatology.
[19] S. Jalkanen,et al. Human Leukocyte Subpopulations from Inflamed Gut Bind to Joint Vasculature Using Distinct Sets of Adhesion Molecules1 , 2001, The Journal of Immunology.
[20] S. Fisher,et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.
[21] M. Dougados,et al. The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies. , 2000, Arthritis and rheumatism.
[22] J. Jover,et al. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. , 2000, The Journal of rheumatology.
[23] G. Jhangri,et al. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. , 2002, Arthritis and rheumatism.
[24] A. Cats,et al. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.
[25] O. Oniankitan,et al. Spondyloarthropathies in sub-Saharan Africa , 2000, Current Opinion in Rheumatology.
[26] S. M. van der Linden,et al. A wider spectrum of spondyloarthropathies. , 1990, Seminars in arthritis and rheumatism.
[27] R. Colbert. HLA-B27 misfolding and spondyloarthropathies: not so groovy after all? , 2000, The Journal of rheumatology.
[28] John C. Davis,et al. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. , 2002, The New England journal of medicine.
[29] A. Silman,et al. The aetiology of psoriatic arthritis. , 2001, Rheumatology.
[30] G. Jhangri,et al. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. , 2001, The Journal of rheumatology.
[31] J. Braun,et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. , 1998, Arthritis and rheumatism.
[32] H. Zeidler,et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial , 2002, The Lancet.
[33] H. Luthra,et al. HLA-B27 and other predisposing factors in spondyloarthropathies. , 1998, Current opinion in rheumatology.
[34] M. Khan,et al. HLA-B27 and its subtypes in world populations. , 1995, Current opinion in rheumatology.
[35] A. Collins,et al. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. , 2000, Rheumatology.
[36] C. Goldsmith,et al. The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--a randomized controlled trial. , 1990, The Journal of rheumatology.
[37] E. Bywaters,et al. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. , 2000, Arthritis and rheumatism.
[38] G. Alarcón,et al. Evaluation of patients with back pain of suspected inflammatory nature. , 1988, The American journal of medicine.
[39] A. Bengtsson,et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. , 1990, BMJ.
[40] M. Khan,et al. HLA-B27 polymorphism and association with disease. , 2000, The Journal of rheumatology.
[41] J. Finkelstein,et al. Occult vertebral fractures in ankylosing spondylitis , 1999, Spinal Cord.
[42] M. Minami,et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. , 2001, The Journal of rheumatology.
[43] T. Yli-Kerttula,et al. Effect of antimicrobial treatment on chronic reactive arthritis. , 1993, Clinical and experimental rheumatology.
[44] M. De Vos,et al. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. , 2000, The Journal of rheumatology.
[45] N. Mehra,et al. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. , 2000, Human immunology.
[46] J. Gran,et al. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway. , 1985, Annals of the rheumatic diseases.
[47] G. Lathrop,et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. , 1992, Arthritis and rheumatism.
[48] I. Olivieri,et al. The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. , 2002, Arthritis and rheumatism.
[49] D. Baeten,et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. , 2002, Arthritis and rheumatism.
[50] R. Lawrence,et al. A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us? , 1997, Archives of internal medicine.
[51] A. Al-Arfaj. Profile of Reiter's disease in Saudi Arabia. , 2001, Clinical and experimental rheumatology.
[52] I. Alvarez,et al. HLA-B27 and immunogenetics of spondyloarthropathies. , 2000, Current opinion in rheumatology.
[53] J. Harley,et al. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[54] A. Cats,et al. Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. , 1985, Arthritis and rheumatism.
[55] F. Hiepe,et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. , 1999, Arthritis and rheumatism.
[56] A. Fleischer,et al. Thalidomide: current and potential clinical applications. , 2000, The American journal of medicine.
[57] J. Braun,et al. Radiologic diagnosis and pathology of the spondyloarthropathies. , 1998, Rheumatic diseases clinics of North America.
[58] J. Richert,et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. , 2001, Arthritis and rheumatism.
[59] A. Clarke,et al. The role of passive stretching in the treatment of ankylosing spondylitis. , 1987, British journal of rheumatology.
[60] S Kunmartini,et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. , 1997, The Journal of rheumatology.
[61] P. Tugwell,et al. Chest pain without radiographic sacroiliitis in relatives of patients with ankylosing spondylitis. , 1988, The Journal of rheumatology.
[62] Y. Konttinen,et al. Inhibition of collagenase by a bisphosphonate-group drug in patients with rheumatoid arthritis. , 2000, The Journal of rheumatology.
[63] E. Märker-Hermann,et al. Psoriatic arthritis: clinical aspects, genetics, and the role of T cells. , 2001, Current opinion in rheumatology.
[64] A. Poole. The histopathology of ankylosing spondylitis: are there unifying hypotheses? , 1998, The American journal of the medical sciences.
[65] M. Benjamin,et al. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites , 2001, Journal of anatomy.
[66] M. Smith. Bacillus Calmette-Guérin induced reactive arthritis. , 2000, The Journal of rheumatology.
[67] B Hamm,et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis— cellularity correlates with the degree of enhancement detected by magnetic resonance imaging , 2000, Annals of the rheumatic diseases.
[68] M. Dougados,et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. , 1999, The Journal of rheumatology.
[69] I. Olivieri,et al. Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset , 2001, Current opinion in rheumatology.
[70] E. Ball,et al. HLA-B27 polymorphism. , 2001, Joint, bone, spine : revue du rhumatisme.
[71] H. Alaranta,et al. Traumatic spinal cord injury as a complication to ankylosing spondylitis. An extended report. , 2002, Clinical and experimental rheumatology.
[72] M. Leirisalo-Repo,et al. Chlamydia pneumoniae as a triggering infection in reactive arthritis. , 1999, Rheumatology.
[73] R. Winchester,et al. Psoriatic arthritis and the spectrum of syndromes related to the SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome. , 1999, Current opinion in rheumatology.
[74] R D Sturrock,et al. Ankylosing spondylitis and HL-A 27. , 1973, Lancet.
[75] R. Hammer,et al. Inflammatory disease in HLA‐B27 transgenic rats , 1999, Immunological reviews.
[76] W. Eyler,et al. PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.
[77] L. Laloux,et al. Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis , 2001, Annals of the rheumatic diseases.
[78] J. Jover,et al. Eye involvement in the spondyloarthropathies. , 1998, Rheumatic diseases clinics of North America.
[79] M. Dougados,et al. Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis. , 1999, Arthritis and rheumatism.
[80] M. Khan,et al. Diagnostic value of HLA-B27 testing ankylosing spondylitis and Reiter's syndrome. , 1982, Annals of internal medicine.
[81] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[82] P. Saikku,et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. , 1991, Arthritis and rheumatism.
[83] W. Maksymowych. Ankylosing spondylitis--at the interface of bone and cartilage. , 2000, The Journal of rheumatology.
[84] D. Weeks,et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. , 2001, American journal of human genetics.
[85] J. Whittum-Hudson,et al. Chlamydia and associated arthritis , 2000, Current opinion in rheumatology.
[86] D. Heijde,et al. ANKYLOSING SPONDYLITIS: Clinical Features , 1998 .
[87] B. Kidd,et al. Delay in diagnosis of spondarthritis. , 1988, British journal of rheumatology.
[88] F. Pons,et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. , 1999, Arthritis and rheumatism.
[89] J. Braun,et al. Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. , 2002, Arthritis and rheumatism.
[90] A. Escudero,et al. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. , 2000, Joint, bone, spine : revue du rhumatisme.
[91] James T. Elder,et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. , 2000, American journal of human genetics.
[92] A. Silman,et al. Genetic studies of psoriatic arthritis: dissecting joints and skin. , 2001, The Journal of rheumatology.
[93] L. Latulippe,et al. [Reactive arthritis]. , 1980, L'union medicale du Canada.
[94] R. Lawrence,et al. Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations. , 1999, The Journal of rheumatology.
[95] M. Khan,et al. Scientific contributions of ankylosing spondylitis patient advocacy groups. , 2000, Current opinion in rheumatology.
[96] E. L. Persons,et al. Ankylosing Spondylitis , 1955, GP.
[97] P. Emery,et al. Enthesitis in spondyloarthropathy. , 1999, Current opinion in rheumatology.
[98] K. Lorig,et al. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. , 1993, Arthritis and rheumatism.
[99] R. Hällgren,et al. Magnetic resonance imaging of sacroiliac joint inflammation. , 1990, Arthritis and rheumatism.
[100] R. Porcher,et al. The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families , 2002, Annals of the rheumatic diseases.
[101] H. Lindsley,et al. Bacillus Calmette-Guérin associated arthropathy mimicking undifferentiated spondyloarthropathy. , 1999, The Journal of rheumatology.
[102] Andre Peeters,et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis , 2000 .
[103] M. Fiorillo,et al. CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. , 2000, The Journal of clinical investigation.
[104] R. Queiró,et al. Subclinical Sacroiliitis in Inflammatory Bowel Disease: A Clinical and Follow-up Study , 2000, Clinical Rheumatology.
[105] J. Reveille,et al. HLA-B27 and genetic predisposing factors in spondyloarthropathies , 2001, Current opinion in rheumatology.
[106] D. M. van der Heijde,et al. Ankylosing spondylitis. Clinical features. , 1998, Rheumatic diseases clinics of North America.
[107] K. Minden,et al. Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides. , 1998, The Journal of rheumatology.
[108] D. Resnick,et al. Focal Spinal Abnormalities on Bone Scans in Ankylosing Spondylitis: A Clue to the Presence of Fracture or Pseudarthrosis , 1981, Clinical nuclear medicine.
[109] R. Hughes,et al. Reiter's syndrome and reactive arthritis: a current view. , 1994, Seminars in arthritis and rheumatism.
[110] Audrey M. Nelson,et al. Textbook of Pediatric Rheumatology , 1990 .
[111] J. Albar,et al. HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. , 1997, Tissue antigens.
[112] T. Sheeran,et al. Chest pain--a common feature of ankylosing spondylitis. , 1988, Postgraduate medical journal.
[113] F. Guillemin,et al. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Société de Rhumatologie de l'Ouest. , 1999, The Journal of rheumatology.
[114] V. Wright,et al. ASSOCIATIONS BETWEEN ANKYLOSING SPONDYLITIS, PSORIATIC ARTHRITIS, REITER'S DISEASE, THE INTESTINAL ARTHROPATHIES, AND BEHCET'S SYNDROME , 1974, Medicine.
[115] R. Himstedt. On the diagnosis of ankylosing spondylitis. , 1952, Rheumatism.
[116] W. Braun,et al. Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. , 1977, Arthritis and rheumatism.
[117] P. Mease,et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial , 2000, The Lancet.
[118] J. Teichmann,et al. Relationship Between Disease Activity and Serum Levels of Vitamin D Metabolites and Parathyroid Hormone in Ankylosing Spondylitis , 2001, Osteoporosis International.
[119] J. Braun,et al. Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response? , 2000, Annals of the rheumatic diseases.
[120] R. Winchester,et al. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. , 1987, Annals of internal medicine.
[121] P. Emery,et al. Classification of inflammatory arthritis by enthesitis , 1998, The Lancet.
[122] P. Pratsidou-Gertsi,et al. Persistent or severe course of reactive arthritis following Salmonella enteritidis infection. A prospective study of 9 cases. , 1998, Scandinavian journal of rheumatology.
[123] M. Crawford,et al. Aortic root disease and valve disease associated with ankylosing spondylitis. , 1998, Journal of the American College of Cardiology.
[124] D. F. Krongard,et al. Diagnosis of ankylosing spondylitis. , 1996, Radiologic technology.
[125] F. Mahmoud,et al. ASSOCIATION OF MHC CLASS I WITH SPONDYLOARTHROPATHIES IN KUWAIT , 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[126] H. Huppertz,et al. Cardiac Manifestations in Patients with HLA B27-Associated Juvenile Arthritis , 2000, Pediatric Cardiology.
[127] R. Mader. Atypical clinical presentation of ankylosing spondylitis. , 1999, Seminars in arthritis and rheumatism.
[128] L. Bergfeldt. HLA-B27-Associated Cardiac Disease , 1997, Annals of Internal Medicine.
[129] M. Dougados,et al. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. , 1999, The Journal of rheumatology.
[130] M. Duruöz,et al. Evaluation of the Amor and ESSG classification criteria for spondylarthropathies in a Turkish population. , 1997, Revue du rhumatisme.
[131] T. Shih,et al. Spinal Fractures and Pseudoarthrosis Complicating Ankylosing Spondylitis: MRI Manifestation and Clinical Significance , 2001, Journal of computer assisted tomography.
[132] E. Veys,et al. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti–tumor necrosis factor therapy , 2001, Current opinion in rheumatology.
[133] A. Calin,et al. Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. , 1997, The Journal of rheumatology.
[134] E. Märker-Hermann,et al. The cutting edge of spondylarthropathy research in the millennium. , 2002, Arthritis and rheumatism.
[135] A. Reiff,et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. , 2000, The New England journal of medicine.